This inventor holds 1 USPTO granted patent and 5 published patent applications and 3 EPO patents. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Tijana Stanic Ljubin: Innovator in Pharmaceutical Compositions
Introduction
Tijana Stanic Ljubin is a notable inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for diabetes treatment. Her work exemplifies the intersection of science and practical application in healthcare.
Latest Patents
Tijana holds a patent for a pharmaceutical composition that combines metformin and sitagliptin. This invention relates to a pharmaceutical dosage form that includes at least two separate compartments. One compartment contains metformin or a pharmaceutically acceptable salt thereof, while the other contains sitagliptin or a pharmaceutically acceptable salt thereof. The patent also outlines a process for preparing these dosage forms, which are designed for the effective treatment of diabetes.
Career Highlights
Throughout her career, Tijana has worked with prominent companies in the pharmaceutical industry, including Lek Pharmaceuticals and Sandoz AG. Her experience in these organizations has allowed her to refine her expertise and contribute to significant advancements in drug formulation.
Collaborations
Tijana has collaborated with several professionals in her field, including Luka Peternel and Uros Klancar. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceutical sciences.
Conclusion
Tijana Stanic Ljubin is a pioneering inventor whose work in pharmaceutical compositions has the potential to improve diabetes treatment. Her contributions reflect a commitment to advancing healthcare through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile